Author:
Beebe-Dimmer Jennifer L.,Ruterbusch Julie J.,Bylsma Lauren C.,Gillezeau Christina,Fryzek Jon,Schultz Neil M.,Flanders Scott C.,Barlev Arie,Heath Elisabeth,Quek Ruben G. W.
Funder
Medivation LLC, a Pfizer company
Astellas Pharma US
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference45 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
2. Shore ND, Chowdhury S, Villers A, Klotz L, Siemens DR, Phung D, et al. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. Lancet Oncol. 2016;17(2):153–63.
3. Senagore AJ. The gale encyclopedia of surgery: G-O, vol. 2. Detroit, MI: Gale Group; 2004. pp. 1051–58.
4. Kreis W, Ahmann FR, Jordan VC, de Haan H, Scott M. Oestrogen pre-treatment abolishes luteinising hormone-releasing hormone testosterone stimulation. Br J Urol. 1988;62(4):352–4.
5. Thompson IM. Flare associated with LHRH-agonist therapy. Rev Urol. 2001;3(Suppl 3):S10–4.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献